Alzheimer's Association campaigns for broader Leqembi coverage
FDA reverses course; will hold adcomm for Sarepta’s DMD gene therapy
Biogen's head of neurodegeneration leaves
Pfizer and Astellas report positive data from prostate cancer therapy trial
*please scroll down for all the latest news*
